Venetoclax for Enhancing Immune Function in CLL and Multiomic Evaluation With Dr. Matthew Cortese

10 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Discover the intricate relationship between CLL, immunosuppression, and the potential of venetoclax to repair immune deficiencies: https://oncdata.com/venetoclax-immune-function-chronic-lymphocytic-leukemia

0:00 Introduction
0:40 Immunosuppressive Effects of CLL
2:00 Role of Venetoclax
4:35 ASH Study and Results
9:53 Future Directions
13:22 How This Affects Patients

In this episode, Dr. Matthew Cortese shares more about his team's ASH study performing a multiomic evaluation of the role of venetoclax in repairing immune deficiences in CLL.

Learn about:
- CLL, its immunosuppressive effects, and the role of venetoclax in enhancing T-cell function
- Their study design and multiomic analysis
- How these findings can shift our understanding of venetoclax's role in treating CLL
- Broader implications for immunotherapy, especially CAR T-cell–based treatments
- Plans for further validation or exploring other potential therapeutic synergies with venetoclax
- Key takeaways for clinicians and patients

#Hematology #CLL #ASH2024 #CLLtreatment #PatientCare #OncologyResearch #HematologyResearch #CancerCare #CancerTreatment #venetoclax #multiomics
Category
Oncology
Be the first to comment

Up Next